Table 2.
Ten-year relative survival in Japanese cancer patients followed-up between 2002 and 2006 (period approach) and conditional 5-year survival of 5-year survivors: Children (0–14 years old) and adolescents and young adults (AYAs, 15–29 years old)
| Children (0–14 years old) |
AYAs (15–29 years old) |
|||||
|---|---|---|---|---|---|---|
| Types of cancer (ICD-10 code) | n | Ten-year relative survival, % (95% CI) | Conditional 5-year survival of 5-year survivors, % (95% CI) | n | Ten-year relative survival, % (95% CI) | Conditional 5-year survival of 5-year survivors, % (95% CI) |
| All sites (C00–C96) | ||||||
| male | 762 | 73.2 (69.8–76.3) | 94.9 (92.7–96.5) | 1060 | 66.0 (62.9–68.9) | 94.5 (92.4–96.0) |
| female | 621 | 79.3 (75.8–82.3) | 96.8 (94.7–98.1) | 1396 | 75.3 (72.8–77.7) | 94.9 (93.2–96.2) |
| Leukemia (C91–C95) | 470 | 76.5 (72.2–80.3) | 96.1 (93.4–97.7) | 277 | 52.5 (46.1–58.6) | 92.3 (83.6–96.4) |
| ALL | 310 | 78.6 (73.3–83.0) | 96.8 (94.7–98.1) | 97 | 36.9 (26.4–47.4) | 87.4 (60.7–96.4) |
| Malignant lymphoma (C81–C85, C96) | 125 | 88.6 (81.4–93.1) | 89.7 (82.6–94.0) | 262 | 73.4 (66.7–78.9) | 93.6 (87.2–96.9) |
| Brain and CNS (C70–C72, C75)† | 271 | 58.0 (51.3–64.2) | 95.5 (90.5–97.9) | 170 | 58.9 (50.8–66.1) | 83.5 (75.2–89.3) |
†
Malignant cases only. ALL, acute lymphoblastic leukemia (ICD O3-M 9811-9818, 9826, 9835-9837); CI, confidence interval; CNS, central nervous system.